Interim results of the publication "Challenges of predicting adverse drug events in distributed analysis" Version 1
The interim results are the results from the local statistical analysis at each centre, which were subsequently pooled in the mixed effects meta-analysis.
Note, that the centres are pseudonymised. Interim results are provided for the subset of centres (out of ten), who provided their consent for sharing the results as they were used for the meta-analysis. The pseudonymised names are those that are mentioned in some of the text files for the meta-analysis.
The folder suffix identifies whether timestamps were considered in the analysis (A-x = no timestamps; B-x = timestamps considered).
The text file contains an overall data description.
LHA ID: 8XW94G4ECE-7
7 items are associated with this Model:- WP_1_5_Data_Description_Healt_Atlas_Leipzig.pdf (PDF document - 272 KB)
- DIZ_8.zip (Zip file - 169 KB)
- DIZ_6.zip (Zip file - 3.16 MB)
- DIZ_5.zip (Zip file - 5 MB)
- DIZ_3.zip (Zip file - 1.54 MB)
- DIZ_2.zip (Zip file - 206 KB)
- DIZ_1.zip (Zip file - 653 KB)
Human Disease: Not specified
Model type: Not specified
Model format: Not specified
Execution or visualisation environment: Not specified
Model image: No image specified
Export PNG
Download
Creators and Submitter
Views: 119 Downloads: 3
Created: 28th Nov 2025 at 08:46
Last used: 12th Dec 2025 at 14:22
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 Created 28th Nov 2025 at 08:46 by Anna Wermund
No revision comments
Related items
The software components and the interim results of the project's article by Wermund et al. (2025; https://doi.org/10.1371/journal.pdig.0000892) are available under "Related Items" > "Models".
Programme: MII - Medical Informatics Initiative
Public web page: https://www.medizininformatik-initiative.de/en/POLAR
The aim of the project is to use methods and processes of the Medical Informatics Initiative (MII) to contribute to the detection of health risks in patients with polypharmacy. Polypharmacy occurs especially in elderly patients with multimorbidity. Polypharmacy associated with an increased risk for medication errors and drug-drug or drug-disease interactions, which either reduce or intensify the desired effect of individual active substances or lead to undesired adverse drug effects (ADE). In the ...
Programme: MII - Medical Informatics Initiative
Public web page: https://www.medizininformatik-initiative.de/en/POLAR
https://orcid.org/0000-0002-5735-0197
The medical informatics initiative was created to close the gap between research and healthcare. All of Germany’s university hospitals have joined forces with research institutions, businesses, health insurers, and patient advocacy groups to create a framework that harnesses research findings to the direct benefit of patients. The German Federal Ministry of Education and Research (BMBF) is investing around 160 million euros in the programme through 2021. The digitisation of medicine is creating ...
Projects: Methodical Use Case PheP, SMITH - Smart Medical Information Technology for Healthcare, WP 1.5 of POLAR_MI (Polypharmacy, Drug Interactions, Risks) - Development of risk models, POLAR - Polypharmacy, Drug Interactions, Risks
